Cardio-oncology checkups to manage heart and metabolic side effects from cancer drugs

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational effort evaluates the cardiovascular and metabolic side effects of anticancer therapies as they occur in routine care across several cardio-oncology programs in France. It uses a structured cardio-oncology checkup and follow-up to document, report, and treat these adverse events. The study focuses on real-world patients managed in Paris-area hospitals, aiming to describe patterns and potential benefits of specialized monitoring. Findings may inform standard practices for preventing and addressing cardiotoxicities in oncology settings.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Suffering a cancer
* Evaluated within a cardio-oncology program

Exclusion Criteria:

* None

Where it's running

• AP-HP, Pitié-Salpêtrière Hospital, Department of Pharmacology, CIC-1421, Pharmacovigilance Unit, INSERM
  Paris, France, France Recruiting
• AP-HP, Saint-Antoine Hospital, Department of cardiology
  Paris, France Recruiting
• AP-HP, Tenon Hospital, Department of Cardiology
  Paris, France Recruiting

Study contacts

• Study coordinator: Joe-Elie Salem, MD, PhD
• Email: joe-elie.salem@aphp.fr
• Phone: (0)1 42 17 85 33

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• 12-Week Solid Beverage Intervention for Suboptimal Health and Metabolic Risk

  A 12-week randomized, double-blind study will test a solid beverage containing postbiotics and plant ingredients to see if it improves glucose, lipids, body composition, and metabolic syndrome indicators in overweight or obese adults with mild metabolic abnormalities.

  Recruiting ChinaNorm · Shanghai, Shanghai Municipality · NCT07884643

• Cardiovascular Outcomes After Adrenalectomy for Pheochromocytoma and Non-secreting Tumors

  This study tests how often and what kinds of cardiovascular problems occur after adrenalectomy for pheochromocytoma or non-secreting tumors.

  Recruiting Central Hospital, Nancy, France · Vandœuvre-lès-Nancy, Lorraine · NCT07200245

• Tropicamide/phenylephrine safety in hospitalized patients

  This project will see if certain health factors make hospitalized adults more likely to have side effects after getting tropicamide/phenylephrine eye drops.

  Recruiting Instituto de Oftalmología Fundación Conde de Valenciana · Mexico City, Mexico Ciy · NCT07178600

• KLN-1010 gene therapy for relapsed or refractory multiple myeloma

  This Phase 1 trial will try KLN-1010, an in vivo CAR‑T gene therapy, to see if it is safe and can be given at a tolerable dose for people with relapsed or refractory multiple myeloma who have had at least three prior therapies.

  Recruiting at 11 sites Phase 1 Kelonia Therapeutics, Inc. · Duarte, California and 10 other locations · NCT07075185

• Comparing two ultrasound methods for femoral artery access in children

  This trial tests whether a modified ultrasound technique helps anesthesia residents place femoral arterial lines faster and with fewer attempts in infants and children having heart surgery.

  Recruiting American University of Beirut Medical Center · Beirut · NCT07059624

• Home Ammonia Monitoring for People with Metabolic Ammonia Disorders

  This study tests whether people with certain ammonia metabolism disorders can successfully measure their ammonia levels at home every day.

  Recruiting Sequitur Health Corp. · Portland, Oregon · NCT06953505

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.